Rectovaginal fistula in a cervical cancer patient treated with sequential radiotherapy and bevacizumab: A dose‐volume analysis

Bevacizumab is a monoclonal antibody against vascular endothelial growth factor that exerts antitumor effect by preventing tumor angiogenesis. Gastrointestinal fistula is a common side effect of bevacizumab in combination with radiotherapy. This case of rectovaginal fistula indicates that the side e...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomizawa, Kento, Ando, Ken, Shimada, Hirofumi, Kaminuma, Takuya, Murata, Kazutoshi, Oike, Takahiro, Ohno, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077241/
https://www.ncbi.nlm.nih.gov/pubmed/33936646
http://dx.doi.org/10.1002/ccr3.3955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077241/
https://www.ncbi.nlm.nih.gov/pubmed/33936646
http://dx.doi.org/10.1002/ccr3.3955

Ejemplares similares